Abstract
Researchers in medicine and pharmacology are working to develop more effective and focused painkillers as a result of growing public awareness of chronic pain brought on by disease and injury. On the other hand, overreliance on medically prescribed painkillers has resulted in several unfavorable outcomes, including drug addiction, tolerance, and other severe side effects that can worsen pain and reduce their efficacy. Drug delivery has benefited from the use of nanotechnology in reducing adverse effects, increasing therapeutic efficacy, and delaying tolerance development. Neuropathic pain is pain that develops as a result of nerve malfunction as well as damage to the somatosensory nervous system. The exact cause of neuropathic pain is not specifically clear. However, many factors, including spinal cord damage, Chronic Constriction Injury (CCI), diabetes, cancer, alcoholism, and trauma, can cause neuropathic pain. There is no doubt that we have many options for conventional treatment, yet either very few patients receive pain relief, or their pain relief is only momentary. Numerous nanocarrier varieties and the accompanying neuropathic pain treatment modalities were also examined. These forms included those based on nonpolymeric nanoparticles, polymeric micelles, lipids, and emulsions. Comparing nanomaterials to other forms of therapy for chronic pain, there are several benefits: reduced side effects, regulated release, and prolonged circulation. Alongside nanotechnology, approaches to treating chronic pain are surface-modification-based and employ a variety of nanoparticles. The current state of the pain-relieving effect of nanomaterial design is covered in the present review article.
Publisher
Innovare Academic Sciences Pvt Ltd